Oncotelic Therapeutics, Inc.
OTLC· OTC
OTLCOncotelic Therapeutics, Inc.
Filed Aug 14, 2018 · 10-Q · 45 days after period end · 0001193125-18-248505
| Metric | Q2 2018 | Q2 2017 | Q2 2016 | Q2 2015 |
|---|---|---|---|---|
| Net Income | -$153.31K | -$3.88M | -$3.64M | -$3.32M |
| EPS Diluted | -$0.03 | -$0.15 | -$0.14 | -$0.13 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oncotelic Therapeutics, Inc. · CIK 908259 · Engraved from SEC EDGAR
ended Jun 30, 2018 · filed Aug 14, 2018 · 45 d after period end
